EWING, N.J., Dec. 6, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that Scott Jackson, chief executive officer, will present an overview of the Company at the upcoming Oppenheimer 24th Annual Healthcare Conference.
Help employers find you! Check out all the jobs and post your resume.
